<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Stevanato Group Spa — News on 6ix</title>
<link>https://6ix.com/company/stevanato-group-spa</link>
<description>Latest news and press releases for Stevanato Group Spa on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Thu, 23 Apr 2026 20:05:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/stevanato-group-spa" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo6835c5e478dffbe2df11acd4.webp</url>
<title>Stevanato Group Spa</title>
<link>https://6ix.com/company/stevanato-group-spa</link>
</image>
<item>
<title>Stevanato Group to Report First Quarter 2026 Financial Results on May 7, 2026</title>
<link>https://6ix.com/company/stevanato-group-spa/news/stevanato-group-to-report-first-quarter-2026-financial-results-on-may-7-2026</link>
<guid isPermaLink="true">https://6ix.com/company/stevanato-group-spa/news/stevanato-group-to-report-first-quarter-2026-financial-results-on-may-7-2026</guid>
<pubDate>Thu, 23 Apr 2026 20:05:00 GMT</pubDate>
<description>PIOMBINO DESE, Italy, April 23, 2026--Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, announced today that it will issue financial results for the first quarter 2026 on Thursday, May 7, 2026, at 6:30 a.m. (EDT).</description>
</item>
<item>
<title>Stevanato Group Delivers 7% Revenue Growth (9% at Constant Currency) for Fiscal Year 2025, Including Record Revenue from High-Value Solutions and Expanded Margins</title>
<link>https://6ix.com/company/stevanato-group-spa/news/stevanato-group-delivers-7percent-revenue-growth-9percent-at-constant-currency-for-fiscal-year-2025-including-record-revenue-from-high-value-solutions-and-expanded-margins</link>
<guid isPermaLink="true">https://6ix.com/company/stevanato-group-spa/news/stevanato-group-delivers-7percent-revenue-growth-9percent-at-constant-currency-for-fiscal-year-2025-including-record-revenue-from-high-value-solutions-and-expanded-margins</guid>
<pubDate>Wed, 04 Mar 2026 11:30:00 GMT</pubDate>
<description>PIOMBINO DESE, Italy, March 04, 2026--Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, today announced its financial results for the fourth quarter and full year 2025.</description>
</item>
<item>
<title>Stevanato Group to Report Fourth Quarter and Fiscal Year 2025 Financial Results on March 4, 2026</title>
<link>https://6ix.com/company/stevanato-group-spa/news/stevanato-group-to-report-fourth-quarter-and-fiscal-year-2025-financial-results-on-march-4-2026</link>
<guid isPermaLink="true">https://6ix.com/company/stevanato-group-spa/news/stevanato-group-to-report-fourth-quarter-and-fiscal-year-2025-financial-results-on-march-4-2026</guid>
<pubDate>Thu, 19 Feb 2026 11:30:00 GMT</pubDate>
<description>PIOMBINO DESE, Italy, February 19, 2026--Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, announced today that it will issue financial results for the fourth quarter and fiscal year 2025 on Wednesday, March 4, 2026, at 6:30 a.m. (ET).</description>
</item>
<item>
<title>Stevanato Group Reports Revenue of €303.2 Million for the Third Quarter of 2025</title>
<link>https://6ix.com/company/stevanato-group-spa/news/stevanato-group-reports-revenue-303-113000386</link>
<guid isPermaLink="true">https://6ix.com/company/stevanato-group-spa/news/stevanato-group-reports-revenue-303-113000386</guid>
<pubDate>Thu, 06 Nov 2025 11:30:00 GMT</pubDate>
<description>PIOMBINO DESE, Italy, November 06, 2025--Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, today announced its financial results for the third quarter of 2025.</description>
</item>
<item>
<title>Stevanato Group to Participate in Upcoming Investor Conferences</title>
<link>https://6ix.com/company/stevanato-group-spa/news/stevanato-group-participate-upcoming-investor-113000280</link>
<guid isPermaLink="true">https://6ix.com/company/stevanato-group-spa/news/stevanato-group-participate-upcoming-investor-113000280</guid>
<pubDate>Fri, 31 Oct 2025 11:30:00 GMT</pubDate>
<description>PIOMBINO DESE, Italy, October 31, 2025--Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, today announced that it will participate in two upcoming investor conferences.</description>
</item>
<item>
<title>Stevanato Group to Report Third Quarter 2025 Financial Results on November 6, 2025</title>
<link>https://6ix.com/company/stevanato-group-spa/news/stevanato-group-report-third-quarter-103000836</link>
<guid isPermaLink="true">https://6ix.com/company/stevanato-group-spa/news/stevanato-group-report-third-quarter-103000836</guid>
<pubDate>Wed, 22 Oct 2025 10:30:00 GMT</pubDate>
<description>PIOMBINO DESE, Italy, October 22, 2025--Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, announced today that it will issue financial results for the third quarter of 2025 on Thursday, November 6, 2025, at 6:30 a.m. (ET).</description>
</item>
<item>
<title>Stevanato Group Expands Drug Delivery Systems Capacity to Strengthen Global Integrated Offerings</title>
<link>https://6ix.com/company/stevanato-group-spa/news/stevanato-group-expands-drug-delivery-103000840</link>
<guid isPermaLink="true">https://6ix.com/company/stevanato-group-spa/news/stevanato-group-expands-drug-delivery-103000840</guid>
<pubDate>Tue, 21 Oct 2025 10:30:00 GMT</pubDate>
<description>PIOMBINO DESE, Italy, October 21, 2025--Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries, announced a significant expansion of its drug delivery system manufacturing capacity, further strengthening its global footprint to meet the industry’s evolving needs.</description>
</item>
<item>
<title>Stevanato Group Reports Revenue of €280.0 Million for the Second Quarter of 2025</title>
<link>https://6ix.com/company/stevanato-group-spa/news/stevanato-group-reports-revenue-280-103000092</link>
<guid isPermaLink="true">https://6ix.com/company/stevanato-group-spa/news/stevanato-group-reports-revenue-280-103000092</guid>
<pubDate>Tue, 05 Aug 2025 10:30:00 GMT</pubDate>
<description>PIOMBINO DESE, Italy, August 05, 2025--Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, today announced its financial results for the second quarter of 2025.</description>
</item>
<item>
<title>Stevanato Group Secures €200 Million in Financing from BNL BNP Paribas, Cassa Depositi e Prestiti, and Banco BPM to Fund Ongoing CAPEX Investments in Italy and the U.S.</title>
<link>https://6ix.com/company/stevanato-group-spa/news/stevanato-group-secures-200-million-103000640</link>
<guid isPermaLink="true">https://6ix.com/company/stevanato-group-spa/news/stevanato-group-secures-200-million-103000640</guid>
<pubDate>Wed, 23 Jul 2025 10:30:00 GMT</pubDate>
<description>PIOMBINO DESE, Italy, July 23, 2025--Stevanato Group S.p.A. (NYSE: STVN), a global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, announced today that it has secured €200 million in financing through agreements with BNL BNP Paribas, Cassa Depositi e Prestiti (CDP), and Banco BPM. These fundings are intended to support the Company’s ongoing capital expenditure projects in Cisterna di Latina (Italy) and Fish</description>
</item>
<item>
<title>Stevanato Group to Report Second Quarter 2025 Financial Results on August 5, 2025</title>
<link>https://6ix.com/company/stevanato-group-spa/news/stevanato-group-report-second-quarter-203000792</link>
<guid isPermaLink="true">https://6ix.com/company/stevanato-group-spa/news/stevanato-group-report-second-quarter-203000792</guid>
<pubDate>Tue, 22 Jul 2025 20:30:00 GMT</pubDate>
<description>PIOMBINO DESE, Italy, July 22, 2025--Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, announced today that it will issue financial results for the second quarter of 2025 on Tuesday, August 5, 2025, at 6:30 a.m. (ET).</description>
</item>
<item>
<title>Stevanato Group Reports Revenue of €256.6 Million for the First Quarter of 2025</title>
<link>https://6ix.com/company/stevanato-group-spa/news/stevanato-group-reports-revenue-256-103700819</link>
<guid isPermaLink="true">https://6ix.com/company/stevanato-group-spa/news/stevanato-group-reports-revenue-256-103700819</guid>
<pubDate>Thu, 08 May 2025 10:37:00 GMT</pubDate>
<description>PIOMBINO DESE, Italy, May 08, 2025--Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, today announced its financial results for the first quarter of 2025.</description>
</item>
<item>
<title>Stevanato Group to Report First Quarter 2025 Financial Results on May 8, 2025</title>
<link>https://6ix.com/company/stevanato-group-spa/news/stevanato-group-report-first-quarter-211500514</link>
<guid isPermaLink="true">https://6ix.com/company/stevanato-group-spa/news/stevanato-group-report-first-quarter-211500514</guid>
<pubDate>Thu, 24 Apr 2025 21:15:00 GMT</pubDate>
<description>PIOMBINO DESE, Italy, April 24, 2025--Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, announced today that it will issue financial results for the first quarter of 2025 on Thursday, May 8, 2025, at 6:30 a.m. (ET).</description>
</item>
<item>
<title>Stevanato Group to Participate in the KeyBanc Capital Markets Virtual Healthcare Forum</title>
<link>https://6ix.com/company/stevanato-group-spa/news/stevanato-group-participate-keybanc-capital-203000395</link>
<guid isPermaLink="true">https://6ix.com/company/stevanato-group-spa/news/stevanato-group-participate-keybanc-capital-203000395</guid>
<pubDate>Tue, 11 Mar 2025 20:30:00 GMT</pubDate>
<description>PIOMBINO DESE, Italy, March 11, 2025--Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, announced today that it will participate in the KeyBanc Capital Markets Healthcare Forum taking place from Tuesday, March 18 to Wednesday, March 19, 2025.</description>
</item>
<item>
<title>Stevanato Group Reports Record Revenue of €1,104 Million for Fiscal Year 2024</title>
<link>https://6ix.com/company/stevanato-group-spa/news/stevanato-group-reports-record-revenue-113100820</link>
<guid isPermaLink="true">https://6ix.com/company/stevanato-group-spa/news/stevanato-group-reports-record-revenue-113100820</guid>
<pubDate>Thu, 06 Mar 2025 11:31:00 GMT</pubDate>
<description>PIOMBINO DESE, Italy, March 06, 2025--Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, today announced its financial results for the fourth quarter and fiscal year 2024.</description>
</item>
<item>
<title>Stevanato Group to Report Fourth Quarter and Fiscal Year 2024 Financial Results on March 6, 2025</title>
<link>https://6ix.com/company/stevanato-group-spa/news/stevanato-group-report-fourth-quarter-210200865</link>
<guid isPermaLink="true">https://6ix.com/company/stevanato-group-spa/news/stevanato-group-report-fourth-quarter-210200865</guid>
<pubDate>Mon, 24 Feb 2025 21:02:00 GMT</pubDate>
<description>PIOMBINO DESE, Italy, February 24, 2025--Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries, announced today that it will issue financial results for the fourth quarter and fiscal year 2024 on Thursday, March 6, 2025, at 6:30 a.m.(ET).</description>
</item>
</channel>
</rss>